Figure 3

Platelet Nadirs in Cycle 1 and Cycle 2 of Treatment for Individual Patients Who Received Eltrombopag and Completed at Least 2 Cycles (n = 11). Patients indicated with an asterisk (*) received eltrombopag for 10 days post-chemotherapy beginning in Cycle 2; all other patients received eltrombopag beginning in Cycle 2 for 5 days pre- and 5 days post-chemotherapy.